Abstract
Purpose
To evaluate the cumulative incidence and estimate the risk factors of Nd:YAG capsulotomy due to posterior cap-sular opacification in adult cataract patients younger than 50 years of age.
Methods
In the present study we retrospectively reviewed 118 consecutive eyes that received phacoemulsification and in-traocular lens implantation. We analyzed the cumulative incidence of Nd:YAG posterior capsulotomy and the associated risk factors.
Results
The cumulative incidence of posterior capsulotomy was 4.24%, 5.08%, 8.47%, 15.25%, and 20.34% in adults younger than 50 years of age at 3 months, 6 months, 12 months, 24 months, and more than 24 months after cataract sur-gery, respectively. The nuclear type (p = 0.021) and the mature type (p = 0.014) cataract groups were strongly associated with an increased risk of posterior capsulotomy compared with the posterior subcapsular type. The hydrophobic and single-piece intraocular lens caused the lowest incidence of posterior capsulotomy among intraocular lenses used for cata-ract surgery (p = 0.028). The subgroup analysis showed no statistical significance between gender, existence of diabetic mellitus or glaucoma, intraocular lens haptic material and the risk of posterior capsulotomy (p > 0.05).
Conclusions
The cumulative incidence of Nd:YAG capsulotomy was 20.34% in adults younger than 50 years of age and at more than 24 months after cataract surgery. The risk factors associated with posterior capsulotomy included nuclear and mature cataract types. Additionally, there was a difference in the incidence of posterior capsulotomy according to the type of intraocular lenses.
References
1. Apple DJ, Solomon KD, Tetz MR. . Posterior capsule opacification. Surv Ophthalmol. 1992; 37:73–116.
3. Awasthi N, Guo S, Wagner BJ. Posterior capsule opacification : a problem reduced but not yet eradicated. Arch Ophthalmol. 2009; 127:555–62.
4. Cobo ML, Ohsawa E, Chandler D. . Pathogenesis of capsular opacification after extracapsular cataract extraction: an animal medel. Ophthalmology. 1984; 91:857–63.
5. Nishi O. Posterior capsule opacification. Part 1. Experimental investigations. J Cataract Refract Surg. 1999; 25:106–17.
6. Miyake K, Ota I, Miyake S, Horiguchi M. Liquefied aftercataract: a complication of continuous curvilinear capsulorhexis and intra-ocular lens implantation in the lens capsule. Am J Ophthalmol. 1998; 125:429–35.
7. Meacock WR, Spalton DJ, Stanford MR. Role of cytokines in the pathogenesis of posterior capsule opacification. Br J Ophthalmol. 2000; 84:332–6.
8. Baratz KH, Cook BE, Hodge DO. Probability of Nd:YAG laser capsulotomy after cataract surgery in Olmsted County, Minnesota. Am J Ophthalmol. 2001; 131:161–6.
9. Ando H, Ando N, Oshika T. Cumulative probability of neo-dymium: YAG laser posterior capsulotomy after phacoemulsification. J Cataract Refract Surg. 2003; 29:2148–54.
10. Liu CS, Wormstone IM, Duncan G. . A study of human lens cell growth in vitro. A model for posterior capsule opacification. Invest Ophthalmol Vis Sci. 1996; 37:906–14.
11. Wormstone IM, Liu CS, Rakic JM. . Human lens epithelial cell proliferation in a protein-free medium. Invest Ophthalmol Vis Sci. 1997; 38:396–404.
12. Dholakia SA, Vasavada AR, Singh R. Prospective evaluation of phacoemulsification in adults younger than 50 years. J Cataract Refract Surg. 2005; 31:1327–33.
13. Schaumberg DA, Dana MR, Christen WG, Glynn RJ. A systematic overview of the incidence of posterior capsule opacification. Ophthalmology. 1998; 105:1213–21.
14. Jung HW, Kim IC. Posterior capsular opacification and Nd: YAG laser capsulotomy in 811B, SI40NB, MA60BM intraocular lens. J Korean Ophthalmol Soc. 2003; 44:1072–8.
15. Lambert SR, Archer SM, Wilson ME. . Long-term outcomes of undercorrection versus full correction after unilateral intraocular lens implantation in children. Am J Ophthalmol. 2012; 153:602–8.
16. Oliver M, Milstein A, Pollack A. Posterior chamber lens im-plantation in infants and juveniles. Eur J Implant Ref Surg. 1990; 2:309–14.
17. Hiroshi A, Nobuyo A, Tetsuro O. Cumulative probability of ne-odymium : YAG laser posterior capsulotomy after phacoemulsi- fication. J Cataract Refract Surg. 2003; 29:2148–54.
18. Argento C, Zárate J. Study of the lens epithelial cell density in cata-ractous eyes operated on with extracapsular and intercapsular techniques. J Cataract Refract Surg. 1990; 16:207–10.
19. Lee MJ, Lee JH. The factors affecting early development of poste-rior capsular opacification after cataract surgery. J Korean Ophthalmol Soc. 2007; 48:493–8.
20. Stark WJ, Worthen D, Holladay JT, Murray G. Neodymium: YAG lasers An FDA report. Ophthalmology. 1985; 92:209–12.
21. Aykan U, Bilge AH, Karadayi K, Akin T. The effect of capsulo-rhexis size on development of posterior capsule opacification: small (4.5 to 5.0 mm) versus large (6.0 to 7.0 mm). Eur J Ophthalmol. 2003; 13:541–5.
22. Bolz M, Menapace R, Findl O. . Effect of anterior capsule pol-ishing on the posterior capsule opacification-inhibiting properties of a sharp-edged, 3-piece, silicone intraocular lens: three- and 5-year results of a randomized trial. J Cataract Refract Surg. 2006; 32:1513–20.
23. Hollick EJ, Spalton DJ, Meacock WR. The effect of capsulorhexis size on posterior capsular opacification: one-year results of a randomized prospective trial. Am J Ophthalmol. 1999; 128:271–9.
24. Sacu S, Menapace R, Wirtitsch M. . Effect of anterior capsule polishing on fibrotic capsule opacification: three-year results. J Cataract Refract Surg. 2004; 30:2322–7.
25. Suh SW, Kim MS. A study of factors influencing after cataract development. J Korean Ophthalmol Soc. 2001; 42:1685–90.
26. Hayashi K, Hayashi H. Posterior capsule opacification after im-plantation of a hydrogel intraocular lens. Br J Ophthalmol. 2004; 88:182–5.
27. Heatley CJ, Spalton DJ, Kumar A. . Comparison of posterior capsule opacification rates between hydrophilic and hydrophobic single-piece acrylic intraocular lenses. J Cataract Refract Surg. 2005; 31:718–24.
28. Kugelberg M, Wejde G, Jayaram H, Zetterstrom C. Posterior cap-sule opacification after implantation of a hydrophilic or a hydro-phobic acrylic intraocular lens: one-year follow-up. J Cataract Refract Surg. 2006; 32:1627–31.
29. Kugelberg M, Wejde G, Jayaram H, Zetterström C. Two-year fol-low-up of posterior capsule opacification after implantation of a hydrophilic or hydrophobic acrylic intraocular lens. Acta Ophthalmol. 2008; 86:533–6.
30. Roesel M, Heinz C, Heimes B. . Uveal and capsular bio-compatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitisda prospective randomized study. Graefes Arch Clin Exp Ophthalmol. 2008; 246:1609–15.
31. Saeed MU, Jafree AJ, Saeed MS. . Intraocular lens and capsule opacification with hydrophilic and hydrophobic acrylic materials. Semin Ophthalmol. 2012; 27:15–8.
32. Mian SI, Fahim K, Marcovitch A. . Nd:YAG capsulotomy rates after use of the AcrySof acrylic three piece and one piece in-traocular lenses. Br J Ophthalmol. 2005; 89:1453–7.
33. Abela-Formanek C, Amon M, Schauersberger J. . Results of hydrophilic acrylic, hydrophobic acrylic, and silicone intraocular lenses in uveitic eyes with cataract: comparison to a control group. J Cataract Refract Surg. 2002; 28:1141–52.
Table 1.
Table 3.
Post-phacoemulsification | Pre-capsulotomy state | Post-capsulotomy state | |
---|---|---|---|
BCVA (log MAR) | 0.23 ± 0.38 | 0.48 ± 0.36 | 0.22 ± 0.38 |
Table 4.
Table 5.
Cataract type | Odds ratio | 95% CI | p-value |
---|---|---|---|
Cortical type | 1.248 | 0.357-4.358 | 0.728* |
Nuclear type | 4.492 | 1.258-16.038 | 0.021* |
Anterior subcapsular type | 0.742 | 0.254-2.162 | 0.584* |
Anterior & posterior subcapsular type | 2.672 | 0.315-22.687 | 0.368* |
Mature type | 20.832 | 1.837-236.247 | 0.014* |
Table 6.
I-FLEX (n = 45) | MI60 (n = 24) | SN60WF (n = 29) | YA60BBR (n = 20) | p-value | |
---|---|---|---|---|---|
Posterior capsulotomy (%) | 16 (35.56) | 4 (16.67) | 2 (6.90) | 4 (20.00) | 0.028* |